Poractant Alfa - Curosurf and SARS-COV-19 ARDS (Covid-19)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.

ClinicalTrials.gov Identifier: NCT04502433

Recruitment Status : Terminated (The enrolment has been extended 2 years but despite the Sponsor's attempts, the current infection status does not permit the identification of eligible patients for the study and to complete it in a reasonable time.)

First Posted : August 6, 2020

Last Update Posted : April 6, 2022

Sponsor:

Information provided by (Responsible Party):

Chiesi Farmaceutici S.p.A.

Study Details
Tabular View
No Results Posted
Disclaimer
How to Read a Study Record

No Study Results Posted on ClinicalTrials.gov for this Study

About Study Results Reporting on ClinicalTrials.gov

Recruitment Status :	Terminated
Actual Primary Completion Date :	March 18, 2022
Actual Study Completion Date :	March 18, 2022

To Top